1. Home
  2. DNUT vs RCKT Comparison

DNUT vs RCKT Comparison

Compare DNUT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krispy Kreme Inc.

DNUT

Krispy Kreme Inc.

HOLD

Current Price

$3.90

Market Cap

585.5M

ML Signal

HOLD

Logo Rocket Pharmaceuticals Inc.

RCKT

Rocket Pharmaceuticals Inc.

HOLD

Current Price

$3.53

Market Cap

534.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DNUT
RCKT
Founded
1937
1999
Country
United States
United States
Employees
N/A
202
Industry
Food Chains
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
585.5M
534.2M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
DNUT
RCKT
Price
$3.90
$3.53
Analyst Decision
Buy
Buy
Analyst Count
6
14
Target Price
$4.72
$29.73
AVG Volume (30 Days)
1.9M
3.8M
Earning Date
05-07-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,522,616,000.00
N/A
Revenue This Year
$0.55
N/A
Revenue Next Year
$3.59
$64.28
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.58
$2.19
52 Week High
$5.73
$8.26

Technical Indicators

Market Signals
Indicator
DNUT
RCKT
Relative Strength Index (RSI) 62.71 41.22
Support Level $3.09 $3.32
Resistance Level $4.63 $4.08
Average True Range (ATR) 0.20 0.19
MACD 0.06 0.01
Stochastic Oscillator 56.28 25.17

Price Performance

Historical Comparison
DNUT
RCKT

About DNUT Krispy Kreme Inc.

Krispy Kreme Inc is a sweet-treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations world-wide. It derives maximum revenue from the U.S. segment.

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

Share on Social Networks: